Table 2.
The most commonly used drugs in monotherapy and combination therapy for anit-IgLON5 disease.
Monotherapy | corticosteroids i.v. |
IVIg | |
plasmapheresis | |
rituximab | |
Combination therapy | IVIg + corticosteroids |
IVIg + plasmapheresis | |
corticosteroids + azathioprine | |
IVIg + mycophenolate mofetil | |
IVIg + cyclophosphamide | |
IVIg + plasmapheresis + rituximab – recommended |
The bold values were implemented to highlight the authors' recommendations considering treatment.